相关实验视频
Updated: Jul 18, 2025

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.9K
对糖尿病辅导计划在自保杂货连锁店的临床结果的评估
Taylor D Mize1, Kendall Guthrie2, Sarah M Oprinovich2
1Clinical Pharmacist, Balls Food Stores, Harrisonville, MO, USA.
Journal of pharmacy practice
|August 26, 2023
概括
药剂师领导的糖尿病指导在员工中显著降低了血红蛋白A1c (HbA1c). 更多的参与者在健康计划干预后实现了控制的糖尿病水平.
科学领域:
- 卫生经济学 卫生经济学
- 临床药房 临床药房
- 糖尿病管理 糖尿病管理
背景情况:
- 糖尿病是一种普遍且昂贵的慢性疾病.
- 自保雇主利用健康计划来降低医疗保健成本.
- 药剂师干预在糖尿病护理和降低成本方面表现有前途.
研究的目的:
- 评估药剂师领导的糖尿病指导计划对血红蛋白A1c (HbA1c) 水平的影响.
- 在自保员工人群中量化HbA1c的减少.
- 评估在企业健康环境中长期药剂师干预的有效性.
主要方法:
- 一个自保杂货连锁店的健康计划中员工的回顾性图表审查.
- 包括2008年至2021年期间参加"现在开始"糖尿病护理计划 (SN-DM) 的患者.
- 对至少有两次记录读数的患者的HbA1c测量的分析.
主要成果:
- 在355名项目参与者中观察到0.61%的平均HbA1c降低 (P < .001).
- 控制糖尿病 (HbA1c <7%) 的患者比例从40%增加到60% (P <.001).
- 较大的HbA1c降低与较高的基线HbA1c相关;与辅导访问频率没有相关性.
结论:
- 参与SN-DM计划导致平均HbA1c的统计学上显著下降.
- 根据美国糖尿病协会的指导方针,药剂师领导的计划改善了糖尿病控制率.
- 员工健康计划包括药剂师领导的糖尿病指导,可以有效地管理慢性疾病并改善健康结果.
更多相关视频
相关概念视频
Diabetes: Management and Pharmacotherapy
310
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
310
Diabetes Mellitus: Type 2 and Gestational
2.5K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
588
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
588
Insulin: Dosing Regimen and Adverse Effects
205
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
205
Diabetes Mellitus: Overview and Type I Subtype
2.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Hypoglycemia and Glucagon
295
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
295

